Where does Biolinq Incorporated rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biolinq Incorporated ranks #9,199 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biolinq Incorporated hold?

Biolinq Incorporated holds 34 US utility patents granted between 2018 and 2025, spanning 6 technology areas.

What is Biolinq Incorporated's Innovation Score?

Biolinq Incorporated has an Innovation Score of 50.7 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biolinq Incorporated focus on?

Biolinq Incorporated's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 19 patents, ranking #930 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Biolinq Incorporated's patent grant rate increasing or decreasing?

Biolinq Incorporated's recent grant velocity is +450% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Biolinq Incorporated's patents?

Biolinq Incorporated's patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biolinq Incorporated patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biolinq Incorporated

USPTO PatentsView assignee record - 34 granted patents across 6 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biolinq ranks #9,199 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 6 technology areas.

#9,199
of 49,997 US assignees by volume: Top 12%
by Innovation Score (50.7/100): 16.3
avg claims per patent: +450%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9199 · US Corporation #9,199 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,199/49,997
PHOTO-FINISH Batesville Services
CPC-NARROW A61B · 6 areas
INNOV-PAR 50.7/100
CLAIMS-RICH 16.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +450% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Batesville Services, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biolinq’s 50.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (24%) Velocity 20.0 pts (39%) Breadth 8.7 pts (17%) Claim depth 9.8 pts (19%)

Qualcomm Incorporated · highest

85
Avast Software s r o · near

51
Biolinq Incorporated · this assignee

51
KOC Universitesi · near

51
O2Micro · near

51
Xylem Europe · near

51
3D Lighting… · lowest

7

What this shows Biolinq's Innovation Score is 50.7/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biolinq?

Each dot is one of Biolinq’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biolinq’s own 16.3 claims/patent is ABOVE the 10.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biolinq vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biolinq's grants concentrate

Biolinq Incorporated is a focused PatentsView assignee: 6 CPC subclasses with 55.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (14 grants) versus a trough of 1 in 2020. By volume, Biolinq sits between Batesville Services, Inc. and Boomi, LP.

Biolinq's three-year grant acceleration

Biolinq Incorporated shows 20 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Batesville Servic…

34
Bayer Oy

34
Belwith Products

34
Biotheryx

34
Blue-white Indust…

34
Bluescope Steel

34
Board of Trustees…

34
Boomi

34
Biolinq Incorpora… ◀

34

What this shows Biolinq holds 34 patents at rank #9,203, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biolinq

By rank, the assignees closest to #9,203 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Biolinq's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biolinq, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Biolinq ranks #930 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

KOC Universitesi 51 O2Micro Inc. 51 Avast Software s.r.o. 51 Xylem Europe GmbH 51

Biolinq's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Biolinq Incorporated patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	5.9%
2019	2	5.9%
2020	1	2.9%
2021	1	2.9%
2022	2	5.9%
2023	4	11.8%
2024	14	41.2%
2025partial year	8	23.5%

Which technologies does Biolinq Incorporated patent most?

A61B - DIAGNOSIS; SURGERY; Identification 19

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biolinq Incorporated's patent record in context - here's where to go next.

Biolinq Incorporated's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 55.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #9,199 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biolinq Incorporated against Batesville Services, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.